U.S. Administration Expands Testosterone Access for Men and Military Personnel

The Food and Drug Administration has removed a long‑standing safety warning on testosterone products and proposed rewriting prescribing instructions to allow the hormone to be used for age‑related symptoms such as low libido and erectile dysfunction. The change is backed by officials in the Trump administration, including Health Secretary Robert F. Kennedy Jr., who argue it will ease access for men who suffer from these common complaints. Medical experts note that recent research supports benefits for sexual health but caution that symptoms overlap with normal aging, raising the risk of misdiagnosis.

Separately, Defense Secretary Pete Hegseth announced a plan to conduct mandatory testosterone screening for all U.S. service members over age 30 and to offer hormone therapy to those found deficient. The proposal, which would also affect women in the armed forces, has drawn criticism from Democratic senators and endocrinologists who say the policy reflects a masculinist agenda and lacks solid scientific justification.